Senior insider sale
Chief Medical Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$910.0K
37.14K shares
What this filing means
WELGUS HOWARD G. plans to sell 37.14K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $910.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001628280-26-029313
Officer· Chief Medical Officer
Since Jan 2020
37.14K
Shares to sell
$910.0K
Approx. market value
7.14K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock option exercise
Cash
6/4/2018
7.14KTotal acquired7.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2018 | Stock option exercise Cash | 7.14K | — |
| Total | 7.14K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
10K
Market value
$238.8K
4/1/2026
—Completed
Units to sell
10K
Market value
$256.5K
3/2/2026
—Completed
Units to sell
10K
Market value
$250.5K
2/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.14K
Market value
$164.2K
5/1/2026
Total
Units
37.14K
Value
$910.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 10K | $238.8K | — | Completed |
3/2/2026 | 10K | $256.5K | — | Completed |
2/2/2026 | 10K | $250.5K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 7.14K | $164.2K | NASDAQ | Planned |
| Total | 37.14K | $910.0K | ||